long half-life and large variability [Regulatives / Guidelines]

posted by Achievwin – US, 2020-08-12 17:22 (1435 d 10:28 ago) – Posting: # 21864
Views: 2,056

Welcome to the home of funky and funny pharmacokinetics where "Garbage in Gospel out" is day of life.

1. allowing long washout periods have seen studies with 4 -5 months washout.
2. other choice we can imagine is Two stage adaptive study design and including ANCOA in place of ANOVA...

want to know what other experts think?

❝ In short:

Complete thread:

UA Flag
 Admin contact
23,107 posts in 4,858 threads, 1,644 registered users;
59 visitors (0 registered, 59 guests [including 8 identified bots]).
Forum time: 03:51 CEST (Europe/Vienna)

All paid jobs absorb and degrade the mind.    Aristotle

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz